ArticleBioscience reports2019

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.

Yogesh Rai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.